Advanced Medical Solutions Group plc is a developer and manufacturer of tissue-healing technologies, focusing on advanced wound care and surgical products. The company operates through two main business units: Wound Care and Surgical. Its Wound Care portfolio includes products for exudate management, infection control, and other advanced wound care technologies. The Surgical unit comprises the Biosurgicals division, which covers wound healing, cardiovascular, orthopaedics, and dental segments, as well as lines for adhesives and sealants, and sutures and supplies. Adhesives and sealants are used to protect incisions, secure internal structures, and create barriers against gastrointestinal leaks.

Summarised from the company's own disclosures, fiscal year ended Oct 2026

Industry Medical Devices Homepage admedsol.com
Sector Healthcare IR page admedsol.com/investor-relations
Tags
wound care, surgical sutures, adhesives, sealants, exudate management, infection control, cardiovascular, orthopaedics, dental, Biosurgicals
Press page —

Metrics

Valuation  
Market cap £ 484.532M
Market cap (USD) $ 642.275M
P/E 57.50
PEG —
P/BV 1.90
P/S 2.12
P/OCF —
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 5.9%
ROI 5.7%
ROIC 5.7%
Profit margin 6.4%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y —
Earnings growth 3y (net profit CAGR) -10.4%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 6.7%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009
Revenue 228.936M 177.521M 126.21M 124.33M 108.601M — 102.368M 102.598M 96.908M — — — 59.499M 52.589M — 31.881M 24.091M
Net profit 14.696M 16.085M 15.889M 20.406M 17.481M — 18.919M 22.65M 20.134M 15.692M 14.119M 12.864M 11.366M 9.692M — — 2.784M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009
Share price 2.2 2.05 1.92 2.24 2.87 2.37 — — — — — — — — — — —
Price performance 12m 0.07 0.07 -0.14 -0.22 0.21 — — — — — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Rule 2.9 Announcement Bull 0 Bear 0 Routine

Oct 26, 2026

Advanced Medical Solutions Group plc
(“AMS” or the “Group”)

Home RNS News Rule 2.9 Announcement Rule 2.9 Announcement

RNS Number : 4515A

Advanced Medical Solutions Grp PLC

26 October 2026

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY) IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

FOR IMMEDIATE RELEASE

26 October 2026

Advanced Medical Solutions Group plc
(“AMS”)

Rule 2.9 Announcement

In accordance with Rule 2.9 of The City Code on Takeovers and Mergers (the “Code“), AMS confirms that, as at the date and time of this announcement, it had 220,999,357 ordinary shares of 5 pence each in issue and admitted to trading on the AIM Market of the London Stock Exchange. AMS does not hold any ordinary shares in treasury. Therefore, the total number of shares with full voting rights in AMS at the above date was 220,999,357.

The International Securities Identification Number (ISIN) for AMS’ ordinary shares is GB0004536594 and AMS’ LEI number is 213800HJP6OWOSZI1L74.

Masters of Aorta and Structural Heart Surgery Bull 0 Bear 0 Routine

October 22, 2026

Dinan, France

Home Past Events Masters of Aorta and Structural Heart Surgery

We are looking forward to attending the 7th MASH

The global aortic and cardiac surgery community will gather in Brittany for the Masters of Aorta and Structural Heart Surgery (MASH). Launched 22 years ago by Professor Jean-Philippe Verhoye, this flagship triennial congress—historically alternating between Brittany and Corsica—is this year led by a multidisciplinary organizing committee comprising Professors Jean-Philippe Verhoye, Jean-François Heautot, Eric Steinmetz, and Jacques Tomasi.

https://mash-congress.com/

📆 22 – 24 October 2026 / 🌍 Dinan, France

Should you attend, please feel most welcome to come and say hello**.**
Get in touch with us to arrange a meeting at the show.

Contact us

Other Events

New Delhi, India

20261120

International Coronary Congress – ICC


Osaka, Japan

20261106

Asia Pacific Hernia Society – APHS2026


Discover

Who We Are

News & Events

Sustainability (ESG)

Carbon Reduction Plan

Climate-Related Financial Disclosures (CFD)

Contact

Investor Relations

At A Glance

Financial Highlights

Our Business

Corporate Governance

Share Price Information

Regulatory News (RNS)

Financial Reports & Results

About AMS

Locations

Brands

Contract Manufacturing

Co-development

Quality Certificates

Gender Pay Report

Modern Slavery Act

Advanced Medical Solutions

Surgical

Woundcare

© 2026 Advanced Medical Solutions Group plc | Terms and Conditions | Cookies | Accessibility | Disclaimer | Privacy Policy

Search for:

DKOU 2026 Bull 0 Bear 0 Routine

October 20, 2026

Berlin

Home Past Events DKOU 2026

We will be attending DKOU 2026!

The German Congress of Orthopaedics and Traumatology (DKOU) is the most important congress in the field in Germany and the largest in Europe. It is also one of the largest congresses for orthopaedics and trauma surgery worldwide. “Exploring new paths” is the motto of DKOU 2026.

https://dkou.org/en/

📆 20 – 23 October 2026 / 🌍 Berlin, Germany

If you are attending, please come and say hello to us at our Booth no. B16.

Prompts

Advanced Medical Solutions Group plc (ticker AMS), listed in United Kingdom.

ETFs Holding Advanced Medical Solutions Group plc

ETF Weight in ETF Shares Market value As of
DFIS 0.03% 416,790 $ 1.561M Nov 12, 2026
AVSD 0.00% 144 $ 535.66 Nov 16, 2026